1st trimester preterm Pre-eclampsia screening – from invention to implementation

Enhanced pre-eclampsia screening utilizing biomarkers was first introduced in early 2000 by Fetal Medicine Foundation (FMF). Evidence to prove added value of biomarkers to enhance traditional screening models has evolved since. In this webinar, the father of FMF pre-eclampsia prediction models, Professor Kypros Nicolaides provides his insights to current developments and future prospects in this field.

As one remarkable milestone in the journey from invention to implementation of pre-eclampsia screening is the first recommendation in public health to offer preterm pre-eclampsia screening to all women in Ontario, Canada. Professor Nanette Okun from University of Toronto will share her experiences in the creation of the recommendation to encourage others through this positive progress.

Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.